Agilent Technologies Inc. (A)
Summary
International Markets and Agilent (A): A Deep Dive for Investors
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance
Agilent Technologies is upgraded to Buy after a strong Q3 2026, with revenue up 8% and EPS up 18% YoY. All three segments posted robust growth, notably Life Sciences and Diagnostics, which saw operating margin jump nearly 600 bps to 23.5%. Guidance for Q4 and FY26 implies continued momentum, with management projecting 6.5–7.5% revenue growth and 8.5% EPS growth for Q4.
Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript
Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript
Agilent Technologies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 6,734 | $916,763.03 | $931,783.58 | $15,020.55 | 1.64% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 3,507 | $559,593.86 | $485,263.59 | -$74,330.27 | -13.28% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 50 | $5,699 | $6,918.5 | $1,219.5 | 21.4% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 2,687 | $262,508.84 | $371,800.19 | $109,291.35 | 41.63% |
 Curtis Ellergodt Rothschild Investment LLC | 3,417 | $408,852.09 | $482,172.87 | $73,320.78 | 17.93% |
Agilent Technologies Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Patrick Donnelly Goldman Sachs | 653.79 | $103,095.53 | $100,395.39 | -$2,700.14 | -2.62% |
 Dan Leonard RBC Capital | 34.17 | $4,071.07 | $5,431.33 | $1,360.26 | 33.41% |
| EK Evie Koslosky Goldman Sachs | 814.1 | $128,376.06 | $125,013.81 | -$3,362.25 | -2.62% |
Agilent Technologies Inc. (A) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Agilent Technologies Inc. ever had a stock split?
Agilent Technologies Inc. Profile
| Professional Services Industry | Industrials Sector | Padraig McDonnell CEO | NYSE Exchange | 00846U101 CUSIP |
| US Country | 18,000 Employees | 30 Jun 2026 Last Dividend | 3 Nov 2014 Last Split | - IPO Date |
Overview
Agilent Technologies, Inc. stands as a global provider offering application-focused solutions primarily to the life sciences, diagnostics, and applied chemical sectors. The company propagates its mission across three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, ensuring a broad spectrum of scientific research, diagnostic, and analytical needs are met worldwide. Since its establishment in 1999, Agilent has cemented its headquarters in Santa Clara, California, from where it orchestrates its global operations, offering an expansive portfolio through direct sales, distributors, resellers, and electronic commerce frameworks.
Products and Services
- Life Sciences and Applied Markets: This segment includes a vast array of technologies such as liquid and gas chromatography systems and components, mass spectrometry systems, spectroscopy instruments, and various laboratory software solutions. It extends to capturing cell analysis with plate-based assays, flow cytometers, real-time cell analyzers, and cell imaging systems, supported by laboratory automation and robotic systems. The emphasis on quality is further underscored by their vacuum pumps and measurement technologies, ensuring precision and efficiency in research and diagnostic activities.
- Diagnostics and Genomics: Emphasizing the critical nature of genomics and nucleic acid research, this segment covers the bases from contract manufacturing to pathology and companion diagnostics. It spans a spectrum that includes reagent partnerships and biomolecular analysis, facilitating advanced diagnostics and extensive research capabilities in the genomic space. This commitment is aimed at pushing the boundaries of molecular diagnostics, providing comprehensive solutions for research and clinical applications.
- Agilent CrossLab: A testament to Agilent’s overarching commitment to support and service, the CrossLab segment provides an exhaustive list of laboratory instrument supplies, including GC and LC columns, sample preparation products, and custom chemistries. Beyond products, CrossLab’s service portfolio is robust, offering everything from repairs, parts, and maintenance to installations, training, and compliance support. With software as a service, asset management, and consulting services, this segment is designed to optimize laboratory operations and enhance the productivity and longevity of research investments.
